Newsroom

March 1, 2021
Fourth quarter 2020 net sales of $1.1 billion , an increase of 11% year-over-year, and reported GAAP net loss of $4 million Non-GAAP organic net sales increased 12% year-over-year Non-GAAP adjusted EBITDA increased 19% year-over-year to $56 million Non-GAAP adjusted net income increased 40%
February 24, 2021
Industry leader Link Welborn , DVM, DABVP to serve as veterinary advocate, advancing the Company's focus on veterinarian-led pet care PORTLAND, Maine --(BUSINESS WIRE)--Feb. 24, 2021-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment
February 22, 2021
New hire underscores commitment to enabling better healthcare outcomes via seamless digital and e-commerce experiences between veterinarians and their clients PORTLAND, Maine --(BUSINESS WIRE)--Feb. 22, 2021-- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today
January 6, 2021
PORTLAND, Maine --(BUSINESS WIRE)--Jan. 6, 2021-- Covetrus ™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that the Company will participate in the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021 .
December 9, 2020
The Company Exits Final Transitional Services Agreement and Announces the Consolidation of its North American Commercial Organizations PORTLAND, Maine --(BUSINESS WIRE)--Dec. 9, 2020-- Covetrus (Nasdaq: CVET), a global leader in animal-health technology and services, announced today that all 72
November 10, 2020
Third quarter GAAP net sales of $1.13 billion , an increase of 11% year-over-year; non-GAAP organic net sales increased 12% year-over-year   Third quarter GAAP net loss of $35 million ; third quarter non-GAAP adjusted net income of $30 million , an increase of 58% year-over-year   Third quarter